Advertisement

Topics

Pierre Guerin Company Profile

01:22 EST 13th December 2018 | BioPortfolio

BIOLAFITTE Aseptic Processes Expertise support the Health Industries focused on the Biotech, Pharmaceutical and Cosmetics markets.

Our areas of competence include :

- Fermenter / Bioreactor process design and manufacturing of complete systems.

- Project management

- Process engineering (P&ID, functional analysis)

- Mechanical design (vessels and piping - 3D isometric drawings)

- Electrical and control system design, programming

- Piping manufacturing and wiring

- Commissioning and after-sales services

- Qualification support (cGMP,GAMP,CFR21 part11)



These technical skills combined with our in house process vessel manufacturing, after-sales service, and distribution network allow us to provide a full range of products and services that meets the needs of our worldwide customer base.

Location

179, Grand'Rue BP 12
79210 MAUZE-SUR-LE-MIGNON
MAUZE
France

Contact

Phone: + 33 (0)5 49 04 78 00
Email: contact@pierreguerin.fr


News Articles [46 Associated News Articles listed on BioPortfolio]

Meet the maker: EPM talks to Pierre van Weperen

In the latest instalment of 'Meet the Maker' EPM talks to Pierre van Weperen, managing director, Ashfield Healthcare. Pierre tells us about working in pharma for 30 years, how everyday decisions can i...

Pierre Fabre gets CHMP positive opinion for melanoma therapy

Pierre Fabre has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European...Read More... The post Pierre Fabre gets CHMP positive opinion for melanoma...

Appointments: Top-Level Changes At J&J, Roche, Pierre Fabre, Nordic Nanovector, Inthera And DDF

This week's announcements include changes at the top of Johnson & Johnson, Roche, Pierre Fabre, Nordic Nanovector, Inthera Bioscience and...  

CrownBio, Pierre Fabre In Immuno-Oncology Alliance

CrownBio to engraft PDX models selected by Pierre Fabre into CD34+ humanized mouse models

Pierre Fabre, Array showcase potential of triple therapy for CRC

Pierre Fabre and Array BioPharma have unveiled data from a late-stage trial showing a significant improvement in one-year survival in colorectal cancer patients taking encorafenib, binimetinib and cet...

FDA approves Pierre Fabre/Array Biotech melanoma combo

US regulators have issued a green light for Pierre Fabre and Array Biotech’s encorafenib/binimetinib combination therapy for advanced BRAF-mutant melanoma.

Apple: große Enttäuschung droht in 2019!

New York (www.aktiencheck.de) - Apple-Aktienanalyse von Analyst Pierre Ferragu von New Street Research: Laut einer Aktienanalyse empfiehlt Analyst Pierre Ferragu vom Investmenthaus New Street Resea...

Pierre Fabre to launch blockchain patient engagement pilot

Pierre Fabre Pharmaceuticals has joined a blockchain consortium that allows patients to share real-time digital health data to inform late-stage clinical research. The French pharma company will work...

PubMed Articles [38 Associated PubMed Articles listed on BioPortfolio]

The Sociology of Pierre Bourdieu: theoretical potential for the subfield of nursing.

to approach the basic conceptions of Pierre Bourdieu's sociology and its articulation with the subfield of nursing by focusing on managerial aspects.

The Optimal Timing of Restaging Resection before Introduction of Bacillus Calmette-Guerin Immunotherapy in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer.

The study aimed to analyze the influence of restaging transurethral resection of bladder tumor (reTURB) timing on outcomes in patients receiving Bacillus Calmette-Guerin (BCG) immunotherapy.

Are There Differences in Toxicity and Efficacy between Various Bacillus Calmette-Guerin Strains in Bladder Cancer Patients? Analysis of 844 Patients.

To evaluate if there are differences in toxicity and efficacy between different Bacillus Calmette-Guerin (BCG) stains used for intravesical immunotherapy in patients with non-muscle invasive bladder c...

A Single Lab Test to Aid Pierre Robin Sequence Severity Diagnosis.

The workup of patients with Pierre Robin sequence (PRS) consists of a physical examination, O saturation, and polysomnography to determine the severity of respiratory obstruction and need for surgery....

Professor Jean-Pierre Relier.

Clinical Trials [50 Associated Clinical Trials listed on BioPortfolio]

Impact of Phonatory and Facial Morphology Disorders, on the Quality of Life of Adolescents With Pierre Robin Sequence

The study team has made the hypothesis that the intensity of the phonatory disorders (rhinolalia), and of the maxillo-mandibular growth anomalies (facial morphology), may have negative eff...

Early Treatment Outcomes in Pierre-Robin-Like Phenotype

In a longitudinal cohort study, we want to assess the effect of the pre-epiglottic baton plate, the main treatment approach currently used in Germany for Pierre-Robin-Like phenotype, on up...

Bioavailability Pilot Study of Versus W0035 Versus Stromectol

Ivermectin is prescribed for the treatment of helminthic infections sensitive to ivermectin. However, it is currently only available as a tablet formulation. W0035 is a powder for oral sus...

Trial of Melaxin Cancer Vaccine Plus Bacillus Calmette-Guerin (BCG) to Treat Malignant Melanoma

The purpose of this study is to determine if treatment with the autologous cellular vaccine, Melaxin, in combination with Bacillus Calmette-Guerin (BCG) injections is effective in Stage I...

Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients

The purpose of this study is to compare the bladder cancer treatments, Mitomycin C (MMC) and Bacillus Calmette Guerin (BCG), to find out which is better. In this study, the patient will ge...

Companies [29 Associated Companies listed on BioPortfolio]

PIERRE GUERIN S.A.S

Supporting Food and Health industriesA specialist in stainless steel products and a designer and manufacturer of process vessels integrating sophisticated and innovative features in agitation, mixing,...

PIERRE GUERIN TECHNOLOGIES

1949Pierre Guérin creates his company in Mauzé sur le Mignon in Southwestern France, developed from a family business in dairy farm equipment and maintenance. Supporting the Food and Health industri...

Pierre Fabre SA

Pierre Fabre group, France's second biggest independent pharmaceutical laboratory, achieved a turnover of 1.75 billion euros in 2008. Approximatively 10,000 people including 1,400 in the research ...

Groupe Pierre Fabre

The Pierre Fabre Group, the second largest independent French pharmaceutical company and leader in the field of in-pharmacy dermo-cosmetics, employs about 10,000 people worldwide, including 1,400 ...

Pierre Guerin

BIOLAFITTE Aseptic Processes Expertise support the Health Industries focused on the Biotech, Pharmaceutical and Cosmetics markets.Our areas of competence include :- Fermenter / Bioreactor process desi...

More Information about "Pierre Guerin" on BioPortfolio

We have published hundreds of Pierre Guerin news stories on BioPortfolio along with dozens of Pierre Guerin Clinical Trials and PubMed Articles about Pierre Guerin for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pierre Guerin Companies in our database. You can also find out about relevant Pierre Guerin Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...


Corporate Database Quicklinks



Searches Linking to this Company Record